Discover NutraLac™
Empowering Motherhood
Nourishing Infancy.
Who We Are
Nutraceutical Technologies International, LLC
Nutraceutical Technologies International, LLC (NTI) is focused on the research and development of clinically documented Nutraceutical nutritional solutions for achieving sustainable health and wellness in populations who are nutritionally at-risk.
Nutraceuticals comprise all-natural derivatives of plant materials that possess phytonutrients with pharmacological values beyond their natural vitamin and mineral content when enzymatically hydrolyzed. Phytonutrients are powerful antioxidants found in certain plants that are beneficial to human health and help prevent various diseases. Our patented enzyme hydrolyzation process embodies a complex of seven specific natural enzymes under specific time/temperature regimes to cleave complex, less efficacious phytonutrients into simple and highly bioavailable nutraceutical components for increased efficacy in the human digestive system. Efficacy is the capacity for beneficial change or therapeutic effect. By ‘predigesting’ these phytonutrients, the NTI enzyme hydrolyzation process enhances the human body’s ability to more effectively utilize the nutritional values embodied in the plant-based phytonutrients.
In this process, complex proteins are reduced to simple proteins (amino acids and peptides) for increased digestibility, while complex fats are broken down into antioxidant-rich fats and free fatty acids, and complex carbohydrates are broken down into less complex polysaccharides for greater absorption in the intestinal tract. When compared to standard enzyme treatments, the proprietary NTI-enhanced enzyme treatment process significantly increases phytonutrients bioavailability for absorption and nutritional efficacy in the human digestive system.
(Ref. U.S. Patent No. 8,945,642 B2).
|
Standard Enzyme Treatment (SET) vs NTI Enhanced Enzyme Treatment (EET) |
||||
|
|
% Solids |
Dry Basis Wt. |
Fat |
Protein |
|
SET Extraction |
7.14 |
7.45 |
0.93 |
0.83 |
|
EET Extraction |
11.41 |
12.89 |
2.50 |
2.65 |
|
% Increase |
59.8% |
73.1% |
167.6% |
220.9% |
Our Current Mission
We are focused on revolutionizing maternal and infant nutrition, thereby empowering lactating mothers and safeguarding the health and development of their breastfed infants. We are driven by a commitment to eradicate the devastating impacts of malnutrition in children.
We are passionate about improving the nutritional wellness of lactating mothers and their breastfed infants during the critical postpartum period from birth to six months of infant development. It is during this period when infants’ digestive systems are not sufficiently developed to properly ingest formula nutritional products. It is a time when newly born infants are most at risk of gastrointestinal diseases, respiratory infections, and immune system deficiencies which expose them to greater risk of cognitive stunting, diminished physical wellness, and even premature death (ref UNICEF Global Report “From the First Hour of Life”).
NutraLac™, NTI’s clinically documented postpartum nutraceutical product, is derived from the phytonutrients embodied in the bran layer of rice. NutraLac focuses on enhancing the nutritional well-being of breastfeeding mothers for the transfer of bioactive phytonutrients benefits to their breastfed infants. NutraLac is a patented postpartum nutraceutical galactagogue for lactating mothers who breastfeed. (Ref. U.S. Patent No. 11,547,135 B2).
Nutraceutical galactagogues are natural phytonutrients with enhanced nutritional benefits to increase the supply, bioavailability, and efficacy of breast milk in lactating mothers. Our NutraLac clinical trials documented infant health and development benefits across all five World Health Organization growth matrixes.
Results of Clinical Trials where mothers took 40g of NutraLac formulation daily for 4.5 months.
|
Anthropometric Indicator |
Initial Z score (1.5 months old) |
Final Z score (6 months old) |
p-value |
||||
|
n |
mean ± st. dev. |
percentile |
n |
mean ± st. dev. |
percentile |
||
|
Weight-for-height (WFH) |
153 |
+0.17 ± 1.3 |
56.75 |
129 |
+0.53 ± 1.0 |
70.19 |
0.00890 |
|
Length-for-age (LFA) |
153 |
-1.90 ± 1.21 |
2.87 |
129 |
-1.78 ± 1.0 |
3.75 |
0.34730 |
|
Weight-for-age (WFA) |
153 |
-1.60 ± 1.3 |
5.48 |
129 |
-.079 ± 1.0 |
21.48 |
<0.0001 |
|
Cephalic perimeter-for-age (CPFA) |
153 |
-1.30 ± 1.14 |
9.68 |
129 |
-1.03 ± .09 |
15.15 |
0.03140 |
|
Body mass index-for-age (BMIFA) |
153 |
-.82 ± 1.33 |
20.61 |
129 |
+0.31 ± 1.3 |
62.17 |
<0.0001 |
Key Statistics
NTI Market Opportunity
NutraLac™ is the only clinically proven, all-natural postpartum nutraceutical galactagogue currently available for lactating mothers who breastfeed.
%
Exclusively Breastfed
46.9% of infants are breastfed exclusively through 3 months, which dips to 25.6% through 6 months.
*CDC, 2020
Breast Milk Challenged
In the U.S., there are 834,000 women aged 18 to 54 facing challenges with breast milk production due to premature births or nutritional deficiencies.
Premature Infants
Every year, more than 380,000 premature infants in the US can be saved from the devastating physical and cognitive impairments caused by nutritional deficits.
$1,200+
Saved per Year
Families who follow optimal breastfeeding practices can save over $1,200 on infant formula within the first year alone.
*Office of the Surgeon General
$40M
Market Value
Securing a 5% share of breastfeeding mothers in the U.S., not on WIC, is projected to yield a market value of $40 million by the end of the fifth year.
%
CAGR
The U.S. baby infant formula market was valued at $3.9627B in 2022 and is anticipated to grow to $6.973B by 2032, a compound annual growth rate (CAGR) of 5.7%.
Mission Statement
Our Vision
Revolutionize maternal and infant nutrition, empowering mothers and safeguarding the health and development of their breastfed infants. We are driven by a commitment to eradicate the devastating impacts of malnutrition during the critical postpartum period, fostering a world where every newborn has the opportunity for a healthy and thriving start to life.
Get In Touch
We are currently evaluating investors to support a go to market strategy to successfully launch and establish the brand over a five-year plan.
Interested parties should reach us by submitting a request.